Pre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic review
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic review
Authors
Keywords
-
Journal
EUROPEAN RADIOLOGY
Volume 22, Issue 12, Pages 2607-2616
Publisher
Springer Nature
Online
2012-09-15
DOI
10.1007/s00330-012-2653-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?
- (2012) Lian-Ming Wu et al. BREAST CANCER RESEARCH AND TREATMENT
- Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIAL
- (2012) Nola M. Hylton et al. RADIOLOGY
- DW-MRI ADC values can predict treatment response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
- (2011) Xi-ru Li et al. MEDICAL ONCOLOGY
- Diffusion-weighted Imaging of the Breast: Principles and Clinical Applications
- (2011) Reiko Woodhams et al. RADIOGRAPHICS
- Accuracy of MRI in Prediction of Pathologic Complete Remission in Breast Cancer After Preoperative Therapy: A Meta-Analysis
- (2010) Ying Yuan et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group
- (2010) Francesco Sardanelli et al. EUROPEAN JOURNAL OF CANCER
- Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging
- (2010) A. Fangberget et al. EUROPEAN RADIOLOGY
- Neoadjuvant chemotherapy for breast cancer: correlation between the baseline MR imaging findings and responses to therapy
- (2010) Takayoshi Uematsu et al. EUROPEAN RADIOLOGY
- Blood oxygen level-dependent MRI for the monitoring of neoadjuvant chemotherapy in breast carcinoma: initial experience
- (2010) Bing Fan et al. MAGNETIC RESONANCE IMAGING
- Quantitative Analysis of Clinical Dynamic Contrast-enhanced MR Imaging for Evaluating Treatment Response in Human Breast Cancer
- (2010) Yanming Yu et al. RADIOLOGY
- Primary Human Breast Adenocarcinoma: Imaging and Histologic Correlates of Intrinsic Susceptibility-weighted MR Imaging before and during Chemotherapy
- (2010) Sonia P. Li et al. RADIOLOGY
- Diffusion-weighted MR Imaging: Pretreatment Prediction of Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
- (2010) Sang Hee Park et al. RADIOLOGY
- Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI
- (2009) Stefan Zwick et al. EUROPEAN RADIOLOGY
- Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative1H MR Spectroscopy
- (2009) Hyeon-Man Baek et al. RADIOLOGY
- Dynamic Contrast-Enhanced MRI for Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: Initial Results
- (2008) Claudette E. Loo et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
- (2008) M.-L. W. Ah-See et al. CLINICAL CANCER RESEARCH
- Breast MRI: guidelines from the European Society of Breast Imaging
- (2008) R. M. Mann et al. EUROPEAN RADIOLOGY
- Can Early Response Assessment Guide Neoadjuvant Chemotherapy in Early-Stage Breast Cancer?
- (2008) F. J. Esteva et al. JNCI-Journal of the National Cancer Institute
- Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase III Randomized GeparTrio Study
- (2008) G. von Minckwitz et al. JNCI-Journal of the National Cancer Institute
- Neoadjuvant Vinorelbine-Capecitabine Versus Docetaxel-Doxorubicin-Cyclophosphamide in Early Nonresponsive Breast Cancer: Phase III Randomized GeparTrio Trial
- (2008) G. von Minckwitz et al. JNCI-Journal of the National Cancer Institute
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started